Vivos (RDGL) EBT Margin Growth (1y) (2011 - 2025)
Vivos (RDGL) EBT Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -287.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 772.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -464.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 233.00 |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | 1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -57,410.00 |
| Mar 31, 2025 | 929,139.00 |
| Sep 30, 2024 | -696,683.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -827,334.00 |
| Sep 30, 2023 | -527,589.00 |
| Jun 30, 2023 | -638,465.00 |
| Mar 31, 2023 | 124,525.00 |
| Sep 30, 2022 | -291,129.00 |
| Sep 30, 2021 | 58,577.00 |
| Sep 30, 2020 | 643,014.00 |
| Mar 31, 2017 | 13.29 Mn |
| Sep 30, 2016 | 1.71 Mn |
| Mar 31, 2016 | -15.63 Mn |
| Mar 31, 2015 | 2.08 Mn |
| Mar 31, 2014 | -526,766.00 |
| Sep 30, 2013 | 279,663.00 |
| Mar 31, 2013 | -80,789.00 |